Development and Validation of Simple, Rapid and Sensitive High- Performance Liquid Chromatographic Method for the Determination of Butenafine Hydrochloride

Aims: The current paper reports a simple, rapid, sensitive, accurate, and precise Reverse-phase high performance liquid chromatography (RP-HPLC) method with wide range of estimation to determine butenafine hydrochloride in nanosponges. This method has been validated as per ICH norms. Study Design: Experimental design with influence of variables such as mobile phase composition, flow rate, temperature and wavelength on the chromatographic peaks. Place and Duration of Study: Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia between Jan 2020 and March 2020. Original Research Article Ansari et al.; JPRI, 32(29): 116-125, 2020; Article no.JPRI.62582 117 Methodology: Separation was achieved by utilizing the most commonly used reverse phase column (C-18, 5 μm, 150 mm x 4.6 mm) set at 30oC and quantified by UV detection at 280 nm after isocratic elution from a mobile phase (70:30 v/v of methanol: phosphate buffer pH 3.0) flowing at 1 ml/min. Results: A sharp and symmetrical peak was observed at 4.08 ± 0.01 minutes. The low variation in peak area and retention time (1.12% and 0.29%, respectively) and a high number of theoretical plates (>2000) indicated this method’s efficiency and suitability. The least square linear regression analysis (Y = 9265.5 X + 1961.4) showed excellent correlation (r = 0.999 ± 0.0003) between concentration and peak area of butenafine hydrochloride through a wide concentration range of 1– 50 μg/ml. The limits of detection and quantification (LOD and LOQ) were 0.18 μg/ml and 0.57 μg/ml, respectively. The assay or determinations were accurate, precise and reproducible with mean accuracy and mean relative standard deviation of precision of 101.53 ± 0.43% and 0.51 ± 0.11% respectively. Conclusion: The developed RP-HPLC method was simple, sensitive, reproducible with wide range of estimation of butenafine hydrochloride in the nanosponges. The proposed method could be used for the analysis of butenafine hydrochloride in the conventional pharmaceutical formulations such as tablets, syrup, creams including novel formulations such as nanoparticles, nanosponges, nanoemulsions. The proposed method overcomes the specificity, sensitivity and reproducibility related issues of ultraviolet-visible spectroscopy.

[1]  M. Rodrigues,et al.  The Still Underestimated Problem of Fungal Diseases Worldwide , 2019, Front. Microbiol..

[2]  B. Fuchs,et al.  Butenafine and analogues: An expeditious synthesis and cytotoxicity and antifungal activities , 2018, Journal of advanced research.

[3]  Felix Bongomin,et al.  Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision , 2017, Journal of fungi.

[4]  Nafisur Rahman,et al.  Analytical techniques in pharmaceutical analysis: A review , 2017 .

[5]  Shikha Gupta,et al.  Topical antifungals used for treatment of seborrheic dermatitis , 2017 .

[6]  Vijay D. Wagh,et al.  Force degradation study of butenafine hydrochloride in bulk and cream formulation , 2016 .

[7]  Josep Esteve-Romero,et al.  Validation of Analytical Methods Based on Chromatographic Techniques: An Overview , 2015 .

[8]  D. McCalley,et al.  Comparison of peak shape in hydrophilic interaction chromatography using acidic salt buffers and simple acid solutions. , 2014, Journal of chromatography. A.

[9]  Masato Kazusaki,et al.  Validation of analytical procedures by high−performance liquid chromatography for pharmaceutical analysis , 2012 .

[10]  I. Biswas,et al.  Studies on comparison of the efficacy of terbinafine 1% cream and butenafine 1% cream for the treatment of Tinea cruris , 2010, Indian Dermatology Online Journal.

[11]  K. Mukkanti,et al.  Simultaneous HPLC Determination of Butenafine Hydrochloride and Betamethasone in a Cream Formulation , 2009, Indian journal of pharmaceutical sciences.

[12]  M. Friedrich,et al.  Epidemiological trends in skin mycoses worldwide , 2008, Mycoses.

[13]  Jiao Jian-yu RP-HPLC determination of content and related substances in butenafine hydrochloride cream , 2006 .

[14]  N. Gow,et al.  Antifungal agents: mechanisms of action. , 2003, Trends in microbiology.

[15]  Z. Qureshi,et al.  Butenafine 1% versus Terbinafine 1% in Cream for the Treatment of Tinea Pedis , 2000 .